Tan, Miraflora .

HRN: 22-51-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2023
CEFUROXIME 1.5GM (VIAL)
06/19/2023
06/26/2023
IV
1.5 G
Q8 X 3 Doses
SP TAH Witb Enterolysis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueIntra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: